This article presents the CSI Clinical Practice Guidelines for Dyslipidemia Management, focusing on early-onset cardiovascular disease in India. It highlights updated lipid targets, the importance of non-HDL cholesterol, and the role of genetics, particularly familial hypercholesterolemia and lipoprotein(a). Emphasizing early detection, aggressive treatment, and laboratory standardization for better outcomes
CSI Clinical Practice Guidelines for Dyslipidemia Management
